LDRT Retreatment for Knee Osteoarthritis
A legfontosabb adatok
- Hol
- Madison (Egyesült Államok)A helyszín megnézése
- Fázis
- 2. fázis
Helyszínek itt: Egyesült Államok
- University of Wisconsin - MadisonMadison, Egyesült ÁllamokContact: Marissa WeissNo longer taking part
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- University of Wisconsin, Madison
- Azonosító
- NCT07933523
- A regiszteradat frissítve
- 2026. november 12.
- Eredeti leírás
The goal of this clinical trial is to learn if one course of low-dose radiation therapy (LDRT) helps as much as two courses of LDRT in people with osteoarthritis.A teljes eredeti leírásKevesebb
UW26092: Low-Dose Radiation Therapy for Osteoarthritis of the Knee: A Phase 2 Randomized Trial of Dual-Course Versus Single-Course Radiation
The goal of this clinical trial is to learn if one course of low-dose radiation therapy (LDRT) helps as much as two courses of LDRT in people with osteoarthritis.
The main questions it aims to answer are whether pain control, joint function, and quality of life are the same with one course of LDRT.
Participants will receive LDRT and can expect to be in the study for up to 3 months.
Bevonási feltételek: Clinical diagnosis of osteoarthritis of the knee; Age ≥40 years at the time of consent; Joint pain which has persisted for ≥3 months; Completed imaging of the involved joint in the past 3 months (including MRI, CT, X-ray, or bone scan); Negative pregnancy test.
Kizáró feltételek: Previous surgery to the affected joint or planned surgery to the affected joint in the next 6 months; Previous radiation treatment targeting the affected joint. Previous radiation targeting any other body site does not exclude from participation as long as there is no clinically meaningful overlap, as determined at the discretion of the treating physician; Current use of prescription medications containing opioids; Confirmed prior diagnosis of rheumatoid arthritis, pseudogout, or gout in the affected joint.